Sigma 1 Receptor and Ion Channel Dynamics in Cancer
- PMID: 28315265
- DOI: 10.1007/978-3-319-50174-1_6
Sigma 1 Receptor and Ion Channel Dynamics in Cancer
Abstract
SigmaR1 is a multitasking chaperone protein which has mainly been studied in CNS physiological and pathophysiological processes such as pain, memory, neurodegenerative diseases (amyotrophic lateral sclerosis , Parkinson's and Alzheimer's diseases, retinal neurodegeneration ), stroke and addiction . Strikingly, G-protein and ion channels are the main client protein fami lies of this atypical chaperone and the recent advances that have been performed for the last 10 years demonstrate that SigmaR1 is principally activated following tissue injury and disease development to promote cell survival. In this chapter, we synthesize the data enhancing our comprehension of the interaction between SigmaR1 and ion channels and the unexpected consequences of such functional coupling in cancer development. We also describe a model in which the pro-survival functions of SigmaR1 observed in CNS pathologies are hijacked by cancer cells to shape their electrical signature and behavior in response to the tumor microenvironment .
Keywords: Angiogenesis; Cancer; Cell cycle; Extra cellular matrix; Integrin; Invasion; Ion channels; Sigma1R; Tumour microenvironment.
Similar articles
-
SIGMAR1 Regulates Membrane Electrical Activity in Response to Extracellular Matrix Stimulation to Drive Cancer Cell Invasiveness.Cancer Res. 2016 Feb 1;76(3):607-18. doi: 10.1158/0008-5472.CAN-15-1465. Epub 2015 Dec 8. Cancer Res. 2016. PMID: 26645564
-
Accumulation of the sigma-1 receptor is common to neuronal nuclear inclusions in various neurodegenerative diseases.Neuropathology. 2014 Apr;34(2):148-58. doi: 10.1111/neup.12080. Epub 2013 Dec 9. Neuropathology. 2014. PMID: 24313828
-
SIGMAR1 Confers Innate Resilience against Neurodegeneration.Int J Mol Sci. 2023 Apr 24;24(9):7767. doi: 10.3390/ijms24097767. Int J Mol Sci. 2023. PMID: 37175473 Free PMC article. Review.
-
Introduction to Sigma Receptors: Their Role in Disease and as Therapeutic Targets.Adv Exp Med Biol. 2017;964:1-4. doi: 10.1007/978-3-319-50174-1_1. Adv Exp Med Biol. 2017. PMID: 28315260 Review.
-
Sigma-1 (σ1) Receptor in Memory and Neurodegenerative Diseases.Handb Exp Pharmacol. 2017;244:81-108. doi: 10.1007/164_2017_15. Handb Exp Pharmacol. 2017. PMID: 28275911 Review.
Cited by
-
Genomic Insights into Oral Cancer Highlight Mutant SIGMAR1 as a Critical Target to Overcome Chemoresistance.Biochem Genet. 2025 Apr 21. doi: 10.1007/s10528-025-11108-0. Online ahead of print. Biochem Genet. 2025. PMID: 40257692
-
Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays.Neuropharmacology. 2018 May 1;133:264-275. doi: 10.1016/j.neuropharm.2018.01.042. Epub 2018 Jan 31. Neuropharmacology. 2018. PMID: 29407216 Free PMC article.
-
Molecular Choreography and Structure of Ca2+ Release-Activated Ca2+ (CRAC) and KCa2+ Channels and Their Relevance in Disease with Special Focus on Cancer.Membranes (Basel). 2020 Dec 15;10(12):425. doi: 10.3390/membranes10120425. Membranes (Basel). 2020. PMID: 33333945 Free PMC article. Review.
-
Suppression of SIGMAR1 hinders oral cancer cell growth via modulation of mitochondrial Ca2+ dynamics.Mol Biol Rep. 2025 Feb 11;52(1):220. doi: 10.1007/s11033-025-10336-2. Mol Biol Rep. 2025. PMID: 39934454
-
Synthesis, radiolabelling, and evaluation of [11C]PB212 as a radioligand for imaging sigma-1 receptors using PET.Am J Nucl Med Mol Imaging. 2018 Feb 5;8(1):32-40. eCollection 2018. Am J Nucl Med Mol Imaging. 2018. PMID: 29531859 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources